Updated analysis of SWOG-directed intergroup study 0116: A phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection

Journal of Clinical Oncology

Volumn 30, Issue 19, 2012, Pages 2327-2333

  Smalley, Stephen R ^a   Benedetti, Jacqueline K ^b   Haller, Daniel G ^d   Hundahl, Scott A ^e   Estes, Norman C ^g   Ajani, Jaffer A ^h   Gunderson, Leonard L ⁱ   Goldman, Bryan ^c   Martenson, James A ^j   Jessup, J Milburn ^k   Stemmermann, Grant N ^l   Blanke, Charles D ^m   Macdonald, John S ^f  

^a Radiation Oncology Center of Olathe   (United States)

^b SWOG STATISTICAL CENTER   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Aptium Oncology   (United States)

^g UNIVERSITY OF ILLINOIS   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ MAYO CLINIC   (United States)

^j MAYO CLINIC   (United States)

^k NATIONAL CANCER INSTITUTE   (United States)

^l UNIVERSITY OF CINCINNATI   (United States)

^m UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADJUVANT CHEMORADIOTHERAPY; ARTICLE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE FREE SURVIVAL; STOMACH CANCER;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; FLUOROURACIL; GASTRECTOMY; HUMANS; LEUCOVORIN; MALE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84864012541     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.36.7136     Document Type: Article

References (50)

1. Wanebo HJ, Kennedy BJ, Chmiel J, et al: Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218:583-592, 1993 (Pubitemid 23339110)
2. Hundahl SA, Menck HR, Mansour EG, et al: The National Cancer Data Base report on gastric carcinoma. Cancer 80:2333-2341, 1997 (Pubitemid 28007405)
3. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 88:921-932, 2000 (Pubitemid 30091113)
4. Dockerty M: Pathologic aspects of primary malignant neoplasms of the stomach, in ReMine W, Priestley J, Berkson J (eds): Cancer of the Stomach. Philadelphia, PA, WB Saunders, 1964, pp 173
5. Gunderson LL, Sosin H: Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8:1-11, 1982 (Pubitemid 12136698)
6. Kennedy BJ: TNM classification for stomach cancer. Cancer 26:971-983, 1970
7. Mari E, Floriani I, Tinazzi A, et al: Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials. A study of GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 11:837-843, 2000
8. Earle CC, Maroun JA: Adjuvant chemotherapy after curative resection for gastric cancer in non- Asian patients: Revisiting a meta-analysis of randomized trials. Eur J Cancer 35:1059-1064, 1999 (Pubitemid 29339187)
9. Hermans J, Bonenkamp JJ. Boon MC, et al: Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials. J Clin Oncol 11:1441-1447, 1993 (Pubitemid 23228247)
10. Janunger K, Hafström L, Nygren P, et al: A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 40:309-326, 2001 (Pubitemid 32588125)
11. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, et al: Benefit of adjuvant chemotherapy for resectable gastric cancer: A meta-analysis. JAMA 303:1729-1737, 2010
12. Shah MA, Ajani JA: Gastric cancer: An enigmatic and heterogeneous disease. JAMA 303:1753-1754, 2010
13. Smalley S, Gunderson L: Stomach, in Perez C, Brady L (eds): Principles and Practice of Radiation Oncology (ed 3). Philadelphia, PA, Lippincott-Raven, 1996
14. Landry J, Tepper JE, Wood WC, et al: Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 19:1357-1362, 1990
15. D'Angelica M, Gonen M, Brennan MF, et al: Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240:808-816, 2004 (Pubitemid 39425773)
16. Hartgrink HH, van de Velde CJ, Putter H, et al: Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 22:2069-2077, 2004
17. Cuschieri A, Weeden S, Fielding J, et al: Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79:1522-1530, 1999 (Pubitemid 29116815)
18. Yonemura Y, Wu CC, Fukushima N, et al: Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol 13:132-137, 2008 (Pubitemid 351668170)
19. Dent DM, Madden MV, Price SK: Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 75:110-112, 1988 (Pubitemid 18078521)
20. Robertson CS, Chung SC, Woods SD, et al: A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 220:176-182, 1994 (Pubitemid 24309416)
21. Takahashi M, Abe M: Intra-operative radiotherapy for carcinoma of the stomach. Eur J Surg Oncol 12:247-250, 1986 (Pubitemid 16006967)
22. Moertel CG, Childs DS Jr, Reitemeier RJ, et al: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 2:865-867, 1969
23. Hallissey MT, Dunn JA, Ward LC, et al: The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: Five-year follow-up. Lancet 343:1309-1312, 1994
24. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 345:725-730, 2001
25. Lauren P: The two histologic main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31-49, 1965
26. Hundahl SA, Macdonald JS, Benedetti J, et al: Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment. Ann Surg Oncol 9:278-286, 2002 (Pubitemid 34298633)
27. Lévy E, Paillarse JM, Votan B: Efficacy of ondansetron in radiation-induced nausea and vomiting: Review of the literature. Bull Cancer Radiother 81:179-185, 1994 (Pubitemid 24320369)
28. Dhar DK, Kubota H, Tachibana M, et al: Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology 59:18-23, 2000 (Pubitemid 30435830)
29. Coburn NG, Swallow CJ, Kiss A, et al: Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 107:2143-2151, 2006 (Pubitemid 44665647)
30. Orsenigo E, Tomajer V, Palo SD, et al: Impact of age on postoperative outcomes in 1118 gastric cancer patients undergoing surgical treatment. Gastric Cancer 10:39-44, 2007 (Pubitemid 46356262)
31. van de Velde C: Resection for gastric cancer in the community. Semin Oncol 32:S90-S93, 2005
32. Helyer LK, O'Brien C, Coburn NG, et al: Surgeons'knowledge of quality indicators for gastric cancer surgery. Gastric Cancer 10:205-214, 2007 (Pubitemid 350308168)
33. Coburn NG, Govindarajan A, Law CH, et al: Stage-specific effect of adjuvant therapy following gastric cancer resection: A population based analysis of 4,041 patients. Ann Surg Oncol 15:500-507, 2008
34. Smith DD, Schwarz RR, Schwarz RE: Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: Data from a large US-population database. J Clin Oncol 28:7114-7124, 2005
35. Le A, Berger D, Lau M, et al: Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States. Ann Surg Oncol 14:2519-2527, 2007 (Pubitemid 47389562)
36. McCulloch P, Nita ME, Kazi H, et al: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev 4:CD001964, 2003
37. Hundahl SA, Peeters KC, Kranenbarg EK, et al: Improved regional control and survival with "low Maruyama Index" surgery in gastric cancer: Autopsy findings form the Dutch D1-D2 Trial. Gastric Cancer 10:84-86, 2007 (Pubitemid 46955945)
38. Yoo CH, Noh SH, Shin DW, et al: Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236-242, 2000 (Pubitemid 30088655)
39. Kim S, Lim DH, Lee J, et al: An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys 63:1279-1285, 2005 (Pubitemid 41628018)
40. Hartgrink HH, van de Velde CJ, Putter H, et al: Neo-adjuvant chemotherapy for operable gastric cancer: Long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol 30:643-649, 2004 (Pubitemid 39060735)
41. Schuhmacher C, Gretschel S, Lordick F, et al: Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organization for Research and Treatment of Cancer Randomized Trial 40954. J Clin Oncol 28:5210-5218, 2010
42. Wu AW, Xu GW Wang HY, et al: Neoadjuvant chemotherapy versus none for resectable gastric cancer. Cochrane Database Syst Rev 18:CD005047, 2007
43. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20, 2006
44. Reference deleted
45. Stahl M, Walz MK, Stuschke M, et al: Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advance adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851-856, 2009
46. Zhang ZX, Gu XZ, Yin WB, et al: Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of the gastric cardia (AGC): Report on 370 patients. Int J Radiat Oncol Biol Phys 42:929-934, 1998
47. Gaast AV, van Hagen P, Hulshof M, et al: Effect of preoperative concurrent chemoradiotherapy on survival of patient with resectable esophageal or esophagogastric junction cancer: Results from a multicenter randomized phase III study. J Clin Oncol 28:302s, 2010 (suppl; abstr 4004)
48. Allal AS, Zwahlen D, Bründler MA, et al: Neoadjuvant radiochemotherapy for locally advanced gastric cancer: Long-term results of a phase I trial. Int J Radiat Oncol Biol Phys 63:1286-1289, 2005 (Pubitemid 41628019)
49. Ajani JA, Mansfield PF, Janjan N, et al: Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol 22:2774-2780, 2004 (Pubitemid 41079894)
50. J.A. Ajani, K. Winter, G.S. Okawara et al.: Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): Quality of combined modality therapy and pathologic response. J Clin Oncol 24: 3953, 2006.